BERKELEY, Calif., Feb. 16, 2021 (SEND2PRESS NEWSWIRE) — Every year, California-based Ethical Traveler reviews the world’s developing nations for their commitment to human rights, social welfare, and environmental protection. The ten destinations with the most impressive records are honored with Ethical Destinations Awards.
Flightpath Biosciences Launches via Illumina Accelerator to Conduct Largest Clinical Biomarker Study in Lyme Disease
| From: Flightpath Biosciences Inc.
BERKELEY, Calif., Feb. 9, 2021 (SEND2PRESS NEWSWIRE) — Flightpath Biosciences, a life sciences company, launched today claiming a spot in Illumina Accelerator’s second global class to develop diagnostics and microbiome-targeted therapeutics to treat rare pathogen-driven diseases. The company has operated in stealth since its founding in mid-2019 and has built a pipeline of drug candidates for a wide range of diseases, starting with acute and Persistent Lyme Disease (PLD).